Actionable news
All posts from Actionable news
Actionable news in AZN: ASTRAZENECA PLC,

Key AstraZeneca drug shown to reduce risk of death from lung cancer

A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014.

AstraZeneca's key immunotherapy drug durvalumab was shown to reduce the risk of stage III lung cancer worsening or causing death in a trial, the pharmaceutical company said on Friday.

The trial results are a boost for a product the company hopes will become a blockbuster drug with sales in the billions of dollars. Astra said it was in active discussion with the authorities over its plans for regulatory submission.

The drug, which will have the brand...